Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: Comparison with CPIB

Janardan Reddy*, Donald Svoboda, Daniel Azarnoff

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: Comparison with CPIB'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science